Medical Care
Global Alpha Particle Targeted Therapy Market Research Report 2025
- Jan 16, 26
- ID: 675868
- Pages: 87
- Figures: 85
- Views: 17
This report aims to provide a comprehensive presentation of the global market for Alpha Particle Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha Particle Targeted Therapy.
The Alpha Particle Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha Particle Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha Particle Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fusion Pharma
Bayer
Roche
Novartis
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
AstraZeneca
AdvanCell
Segment by Type
Antibodies
Peptides or Small Molecules
Segment by Application
Basic Radiochemistry
Clinical Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha Particle Targeted Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Alpha Particle Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha Particle Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha Particle Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fusion Pharma
Bayer
Roche
Novartis
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
AstraZeneca
AdvanCell
Segment by Type
Antibodies
Peptides or Small Molecules
Segment by Application
Basic Radiochemistry
Clinical Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha Particle Targeted Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibodies
1.2.3 Peptides or Small Molecules
1.3 Market by Application
1.3.1 Global Alpha Particle Targeted Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Basic Radiochemistry
1.3.3 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha Particle Targeted Therapy Market Perspective (2020-2031)
2.2 Global Alpha Particle Targeted Therapy Growth Trends by Region
2.2.1 Global Alpha Particle Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alpha Particle Targeted Therapy Historic Market Size by Region (2020-2025)
2.2.3 Alpha Particle Targeted Therapy Forecasted Market Size by Region (2026-2031)
2.3 Alpha Particle Targeted Therapy Market Dynamics
2.3.1 Alpha Particle Targeted Therapy Industry Trends
2.3.2 Alpha Particle Targeted Therapy Market Drivers
2.3.3 Alpha Particle Targeted Therapy Market Challenges
2.3.4 Alpha Particle Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha Particle Targeted Therapy Players by Revenue
3.1.1 Global Top Alpha Particle Targeted Therapy Players by Revenue (2020-2025)
3.1.2 Global Alpha Particle Targeted Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Alpha Particle Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alpha Particle Targeted Therapy Revenue
3.4 Global Alpha Particle Targeted Therapy Market Concentration Ratio
3.4.1 Global Alpha Particle Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Particle Targeted Therapy Revenue in 2024
3.5 Global Key Players of Alpha Particle Targeted Therapy Head office and Area Served
3.6 Global Key Players of Alpha Particle Targeted Therapy, Product and Application
3.7 Global Key Players of Alpha Particle Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha Particle Targeted Therapy Breakdown Data by Type
4.1 Global Alpha Particle Targeted Therapy Historic Market Size by Type (2020-2025)
4.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (2026-2031)
5 Alpha Particle Targeted Therapy Breakdown Data by Application
5.1 Global Alpha Particle Targeted Therapy Historic Market Size by Application (2020-2025)
5.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alpha Particle Targeted Therapy Market Size (2020-2031)
6.2 North America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
6.4 North America Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha Particle Targeted Therapy Market Size (2020-2031)
7.2 Europe Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
7.4 Europe Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha Particle Targeted Therapy Market Size (2020-2031)
8.2 Asia-Pacific Alpha Particle Targeted Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha Particle Targeted Therapy Market Size (2020-2031)
9.2 Latin America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
9.4 Latin America Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha Particle Targeted Therapy Market Size (2020-2031)
10.2 Middle East & Africa Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fusion Pharma
11.1.1 Fusion Pharma Company Details
11.1.2 Fusion Pharma Business Overview
11.1.3 Fusion Pharma Alpha Particle Targeted Therapy Introduction
11.1.4 Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.1.5 Fusion Pharma Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Alpha Particle Targeted Therapy Introduction
11.2.4 Bayer Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Alpha Particle Targeted Therapy Introduction
11.3.4 Roche Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Alpha Particle Targeted Therapy Introduction
11.4.4 Novartis Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Orano Med
11.5.1 Orano Med Company Details
11.5.2 Orano Med Business Overview
11.5.3 Orano Med Alpha Particle Targeted Therapy Introduction
11.5.4 Orano Med Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.5.5 Orano Med Recent Development
11.6 Oncoinvent AS
11.6.1 Oncoinvent AS Company Details
11.6.2 Oncoinvent AS Business Overview
11.6.3 Oncoinvent AS Alpha Particle Targeted Therapy Introduction
11.6.4 Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.6.5 Oncoinvent AS Recent Development
11.7 Perspective Therapeutics
11.7.1 Perspective Therapeutics Company Details
11.7.2 Perspective Therapeutics Business Overview
11.7.3 Perspective Therapeutics Alpha Particle Targeted Therapy Introduction
11.7.4 Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.7.5 Perspective Therapeutics Recent Development
11.8 Ablaze Pharma
11.8.1 Ablaze Pharma Company Details
11.8.2 Ablaze Pharma Business Overview
11.8.3 Ablaze Pharma Alpha Particle Targeted Therapy Introduction
11.8.4 Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.8.5 Ablaze Pharma Recent Development
11.9 ARTBIO
11.9.1 ARTBIO Company Details
11.9.2 ARTBIO Business Overview
11.9.3 ARTBIO Alpha Particle Targeted Therapy Introduction
11.9.4 ARTBIO Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.9.5 ARTBIO Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Alpha Particle Targeted Therapy Introduction
11.10.4 AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 AdvanCell
11.11.1 AdvanCell Company Details
11.11.2 AdvanCell Business Overview
11.11.3 AdvanCell Alpha Particle Targeted Therapy Introduction
11.11.4 AdvanCell Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.11.5 AdvanCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibodies
1.2.3 Peptides or Small Molecules
1.3 Market by Application
1.3.1 Global Alpha Particle Targeted Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Basic Radiochemistry
1.3.3 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha Particle Targeted Therapy Market Perspective (2020-2031)
2.2 Global Alpha Particle Targeted Therapy Growth Trends by Region
2.2.1 Global Alpha Particle Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alpha Particle Targeted Therapy Historic Market Size by Region (2020-2025)
2.2.3 Alpha Particle Targeted Therapy Forecasted Market Size by Region (2026-2031)
2.3 Alpha Particle Targeted Therapy Market Dynamics
2.3.1 Alpha Particle Targeted Therapy Industry Trends
2.3.2 Alpha Particle Targeted Therapy Market Drivers
2.3.3 Alpha Particle Targeted Therapy Market Challenges
2.3.4 Alpha Particle Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha Particle Targeted Therapy Players by Revenue
3.1.1 Global Top Alpha Particle Targeted Therapy Players by Revenue (2020-2025)
3.1.2 Global Alpha Particle Targeted Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Alpha Particle Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alpha Particle Targeted Therapy Revenue
3.4 Global Alpha Particle Targeted Therapy Market Concentration Ratio
3.4.1 Global Alpha Particle Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Particle Targeted Therapy Revenue in 2024
3.5 Global Key Players of Alpha Particle Targeted Therapy Head office and Area Served
3.6 Global Key Players of Alpha Particle Targeted Therapy, Product and Application
3.7 Global Key Players of Alpha Particle Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha Particle Targeted Therapy Breakdown Data by Type
4.1 Global Alpha Particle Targeted Therapy Historic Market Size by Type (2020-2025)
4.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (2026-2031)
5 Alpha Particle Targeted Therapy Breakdown Data by Application
5.1 Global Alpha Particle Targeted Therapy Historic Market Size by Application (2020-2025)
5.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alpha Particle Targeted Therapy Market Size (2020-2031)
6.2 North America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
6.4 North America Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha Particle Targeted Therapy Market Size (2020-2031)
7.2 Europe Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
7.4 Europe Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha Particle Targeted Therapy Market Size (2020-2031)
8.2 Asia-Pacific Alpha Particle Targeted Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha Particle Targeted Therapy Market Size (2020-2031)
9.2 Latin America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
9.4 Latin America Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha Particle Targeted Therapy Market Size (2020-2031)
10.2 Middle East & Africa Alpha Particle Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fusion Pharma
11.1.1 Fusion Pharma Company Details
11.1.2 Fusion Pharma Business Overview
11.1.3 Fusion Pharma Alpha Particle Targeted Therapy Introduction
11.1.4 Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.1.5 Fusion Pharma Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Alpha Particle Targeted Therapy Introduction
11.2.4 Bayer Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Alpha Particle Targeted Therapy Introduction
11.3.4 Roche Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Alpha Particle Targeted Therapy Introduction
11.4.4 Novartis Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Orano Med
11.5.1 Orano Med Company Details
11.5.2 Orano Med Business Overview
11.5.3 Orano Med Alpha Particle Targeted Therapy Introduction
11.5.4 Orano Med Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.5.5 Orano Med Recent Development
11.6 Oncoinvent AS
11.6.1 Oncoinvent AS Company Details
11.6.2 Oncoinvent AS Business Overview
11.6.3 Oncoinvent AS Alpha Particle Targeted Therapy Introduction
11.6.4 Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.6.5 Oncoinvent AS Recent Development
11.7 Perspective Therapeutics
11.7.1 Perspective Therapeutics Company Details
11.7.2 Perspective Therapeutics Business Overview
11.7.3 Perspective Therapeutics Alpha Particle Targeted Therapy Introduction
11.7.4 Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.7.5 Perspective Therapeutics Recent Development
11.8 Ablaze Pharma
11.8.1 Ablaze Pharma Company Details
11.8.2 Ablaze Pharma Business Overview
11.8.3 Ablaze Pharma Alpha Particle Targeted Therapy Introduction
11.8.4 Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.8.5 Ablaze Pharma Recent Development
11.9 ARTBIO
11.9.1 ARTBIO Company Details
11.9.2 ARTBIO Business Overview
11.9.3 ARTBIO Alpha Particle Targeted Therapy Introduction
11.9.4 ARTBIO Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.9.5 ARTBIO Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Alpha Particle Targeted Therapy Introduction
11.10.4 AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 AdvanCell
11.11.1 AdvanCell Company Details
11.11.2 AdvanCell Business Overview
11.11.3 AdvanCell Alpha Particle Targeted Therapy Introduction
11.11.4 AdvanCell Revenue in Alpha Particle Targeted Therapy Business (2020-2025)
11.11.5 AdvanCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibodies
Table 3. Key Players of Peptides or Small Molecules
Table 4. Global Alpha Particle Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Alpha Particle Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Alpha Particle Targeted Therapy Market Share by Region (2020-2025)
Table 8. Global Alpha Particle Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Alpha Particle Targeted Therapy Market Share by Region (2026-2031)
Table 10. Alpha Particle Targeted Therapy Market Trends
Table 11. Alpha Particle Targeted Therapy Market Drivers
Table 12. Alpha Particle Targeted Therapy Market Challenges
Table 13. Alpha Particle Targeted Therapy Market Restraints
Table 14. Global Alpha Particle Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Alpha Particle Targeted Therapy Market Share by Players (2020-2025)
Table 16. Global Top Alpha Particle Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Particle Targeted Therapy as of 2024)
Table 17. Ranking of Global Top Alpha Particle Targeted Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Alpha Particle Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Alpha Particle Targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of Alpha Particle Targeted Therapy, Product and Application
Table 21. Global Key Players of Alpha Particle Targeted Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Alpha Particle Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Alpha Particle Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Alpha Particle Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Fusion Pharma Company Details
Table 47. Fusion Pharma Business Overview
Table 48. Fusion Pharma Alpha Particle Targeted Therapy Product
Table 49. Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 50. Fusion Pharma Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Alpha Particle Targeted Therapy Product
Table 54. Bayer Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Alpha Particle Targeted Therapy Product
Table 59. Roche Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Alpha Particle Targeted Therapy Product
Table 64. Novartis Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Orano Med Company Details
Table 67. Orano Med Business Overview
Table 68. Orano Med Alpha Particle Targeted Therapy Product
Table 69. Orano Med Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 70. Orano Med Recent Development
Table 71. Oncoinvent AS Company Details
Table 72. Oncoinvent AS Business Overview
Table 73. Oncoinvent AS Alpha Particle Targeted Therapy Product
Table 74. Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 75. Oncoinvent AS Recent Development
Table 76. Perspective Therapeutics Company Details
Table 77. Perspective Therapeutics Business Overview
Table 78. Perspective Therapeutics Alpha Particle Targeted Therapy Product
Table 79. Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 80. Perspective Therapeutics Recent Development
Table 81. Ablaze Pharma Company Details
Table 82. Ablaze Pharma Business Overview
Table 83. Ablaze Pharma Alpha Particle Targeted Therapy Product
Table 84. Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 85. Ablaze Pharma Recent Development
Table 86. ARTBIO Company Details
Table 87. ARTBIO Business Overview
Table 88. ARTBIO Alpha Particle Targeted Therapy Product
Table 89. ARTBIO Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 90. ARTBIO Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Alpha Particle Targeted Therapy Product
Table 94. AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. AdvanCell Company Details
Table 97. AdvanCell Business Overview
Table 98. AdvanCell Alpha Particle Targeted Therapy Product
Table 99. AdvanCell Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 100. AdvanCell Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Alpha Particle Targeted Therapy Picture
Figure 2. Global Alpha Particle Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alpha Particle Targeted Therapy Market Share by Type: 2024 VS 2031
Figure 4. Antibodies Features
Figure 5. Peptides or Small Molecules Features
Figure 6. Global Alpha Particle Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Alpha Particle Targeted Therapy Market Share by Application: 2024 VS 2031
Figure 8. Basic Radiochemistry Case Studies
Figure 9. Clinical Research Case Studies
Figure 10. Alpha Particle Targeted Therapy Report Years Considered
Figure 11. Global Alpha Particle Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Alpha Particle Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Alpha Particle Targeted Therapy Market Share by Region: 2024 VS 2031
Figure 14. Global Alpha Particle Targeted Therapy Market Share by Players in 2024
Figure 15. Global Top Alpha Particle Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Particle Targeted Therapy as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Alpha Particle Targeted Therapy Revenue in 2024
Figure 17. North America Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 19. United States Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 23. Germany Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Alpha Particle Targeted Therapy Market Share by Region (2020-2031)
Figure 31. China Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 39. Mexico Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 43. Turkey Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Fusion Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 47. Bayer Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 48. Roche Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 49. Novartis Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 50. Orano Med Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 51. Oncoinvent AS Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 52. Perspective Therapeutics Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 53. Ablaze Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 54. ARTBIO Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 56. AdvanCell Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibodies
Table 3. Key Players of Peptides or Small Molecules
Table 4. Global Alpha Particle Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Alpha Particle Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Alpha Particle Targeted Therapy Market Share by Region (2020-2025)
Table 8. Global Alpha Particle Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Alpha Particle Targeted Therapy Market Share by Region (2026-2031)
Table 10. Alpha Particle Targeted Therapy Market Trends
Table 11. Alpha Particle Targeted Therapy Market Drivers
Table 12. Alpha Particle Targeted Therapy Market Challenges
Table 13. Alpha Particle Targeted Therapy Market Restraints
Table 14. Global Alpha Particle Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Alpha Particle Targeted Therapy Market Share by Players (2020-2025)
Table 16. Global Top Alpha Particle Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Particle Targeted Therapy as of 2024)
Table 17. Ranking of Global Top Alpha Particle Targeted Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Alpha Particle Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Alpha Particle Targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of Alpha Particle Targeted Therapy, Product and Application
Table 21. Global Key Players of Alpha Particle Targeted Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Alpha Particle Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Alpha Particle Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Alpha Particle Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Fusion Pharma Company Details
Table 47. Fusion Pharma Business Overview
Table 48. Fusion Pharma Alpha Particle Targeted Therapy Product
Table 49. Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 50. Fusion Pharma Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Alpha Particle Targeted Therapy Product
Table 54. Bayer Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Alpha Particle Targeted Therapy Product
Table 59. Roche Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Alpha Particle Targeted Therapy Product
Table 64. Novartis Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Orano Med Company Details
Table 67. Orano Med Business Overview
Table 68. Orano Med Alpha Particle Targeted Therapy Product
Table 69. Orano Med Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 70. Orano Med Recent Development
Table 71. Oncoinvent AS Company Details
Table 72. Oncoinvent AS Business Overview
Table 73. Oncoinvent AS Alpha Particle Targeted Therapy Product
Table 74. Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 75. Oncoinvent AS Recent Development
Table 76. Perspective Therapeutics Company Details
Table 77. Perspective Therapeutics Business Overview
Table 78. Perspective Therapeutics Alpha Particle Targeted Therapy Product
Table 79. Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 80. Perspective Therapeutics Recent Development
Table 81. Ablaze Pharma Company Details
Table 82. Ablaze Pharma Business Overview
Table 83. Ablaze Pharma Alpha Particle Targeted Therapy Product
Table 84. Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 85. Ablaze Pharma Recent Development
Table 86. ARTBIO Company Details
Table 87. ARTBIO Business Overview
Table 88. ARTBIO Alpha Particle Targeted Therapy Product
Table 89. ARTBIO Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 90. ARTBIO Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Alpha Particle Targeted Therapy Product
Table 94. AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. AdvanCell Company Details
Table 97. AdvanCell Business Overview
Table 98. AdvanCell Alpha Particle Targeted Therapy Product
Table 99. AdvanCell Revenue in Alpha Particle Targeted Therapy Business (2020-2025) & (US$ Million)
Table 100. AdvanCell Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Alpha Particle Targeted Therapy Picture
Figure 2. Global Alpha Particle Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alpha Particle Targeted Therapy Market Share by Type: 2024 VS 2031
Figure 4. Antibodies Features
Figure 5. Peptides or Small Molecules Features
Figure 6. Global Alpha Particle Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Alpha Particle Targeted Therapy Market Share by Application: 2024 VS 2031
Figure 8. Basic Radiochemistry Case Studies
Figure 9. Clinical Research Case Studies
Figure 10. Alpha Particle Targeted Therapy Report Years Considered
Figure 11. Global Alpha Particle Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Alpha Particle Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Alpha Particle Targeted Therapy Market Share by Region: 2024 VS 2031
Figure 14. Global Alpha Particle Targeted Therapy Market Share by Players in 2024
Figure 15. Global Top Alpha Particle Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Particle Targeted Therapy as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Alpha Particle Targeted Therapy Revenue in 2024
Figure 17. North America Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 19. United States Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 23. Germany Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Alpha Particle Targeted Therapy Market Share by Region (2020-2031)
Figure 31. China Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 39. Mexico Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Alpha Particle Targeted Therapy Market Share by Country (2020-2031)
Figure 43. Turkey Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Alpha Particle Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Fusion Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 47. Bayer Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 48. Roche Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 49. Novartis Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 50. Orano Med Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 51. Oncoinvent AS Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 52. Perspective Therapeutics Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 53. Ablaze Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 54. ARTBIO Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 56. AdvanCell Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232